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Abstract
During the course of a microbial infection, different antigen presenting cells (APCs) are exposed and contribute to the
ensuing immune response. CD8a+ dendritic cells (DCs) are an important coordinator of early immune responses to the
intracellular bacteria Listeria monocytogenes (Lm) and are crucial for CD8+ T cell immunity. In this study, we examine the
contribution of different primary APCs to inducing immune responses against Lm. We find that CD8a+ DCs are the most
susceptible to infection while plasmacytoid DCs are not infected. Moreover, CD8a+ DCs are the only DC subset capable of
priming an immune response to Lm in vitro and are also the only APC studied that do so when transferred into b2
microglobulin deficient mice which lack endogenous cross-presentation. Upon infection, CD11b+ DCs primarily secrete low
levels of TNFa while CD8a+ DCs secrete IL-12 p70. Infected monocytes secrete high levels of TNFa and IL-12p70, cytokines
associated with activated inflammatory macrophages. Furthermore, co-culture of infected CD8a+ DCs and CD11b+ DCs with
monocytes enhances production of IL-12 p70 and TNFa. However, the presence of monocytes in DC/T cell co-cultures
attenuates T cell priming against Lm-derived antigens in vitro and in vivo. This suppressive activity of spleen-derived
monocytes is mediated in part by both TNFa and inducible nitric oxide synthase (iNOS). Thus these monocytes enhance IL-
12 production to Lm infection, but concurrently abrogate DC-mediated T cell priming.
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Introduction
Host defenses against intracellular pathogens, including the
gram-positive bacterium Listeria monocytogenes (Lm), require coordi-
nated interactions between a number of innate and adaptive
components to clear an infection (reviewed in [1,2,3,4]). The
mouse model for Lm infection shows that protective immunity
requires a complex interplay between a number of innate effectors
including neutrophils, macrophages and NK cells [5,6,7,8,9,
10,11]. Both Interferon gamma (IFNc) (primarily from NK cells)
and tumor necrosis factor alpha (TNFa) are essential for early
resistance to infection [11,12,13,14]. Innate defenses against Lm
were shown to depend on TNFa and inducible nitric oxide
synthase (iNOS) producing DCs (TipDCs) (the precursors of
which may be monocytes) [5,6,15]. On the other hand, secretion
of Type I IFNs upon cytosolic entry by Lm appears to impair the
response to Lm [15,16,17]. These innate cells are required early
for host survival and bacterial clearance [5,6,7,8,9,10,11,18], while
development of adaptive immunity and immunologic memory
requires lymphocytes such as CD4+ and CD8+ T cells, the latter
being crucial for long-term protection from subsequent exposures.
At the crossroads of innate and adaptive immunity are DCs,
and in the context of host-pathogen interactions the major subsets
appear to be CD8a+ DCs, CD11b+ DCs and plasmacytoid DCs
(PDCs) (Reviewed in [19,20,21,22]). Lm-specific adaptive respons-
es have been demonstrated to require DCs [23], and studies have
shown that DCs themselves can be early targets (within 3–6 hrs) of
Lm in the spleen [24,25]. Alternatively, Lm can be initially taken
up by monocytes, macrophages, and neutrophils to trigger an
innate immune response. Antigen from these infected cells may
then be taken up by DCs, and subsequent priming of CD8+ T
occurs via cross-presentation of these acquired antigens by CD8a+
DCs. Consistent with this hypothesis, CD8a+ DCs specifically
have been implicated in both early bacterial clearance [25], and in
priming of T cells to Lm–encoded antigens [26].
Nevertheless, while it was believed that the DC subset with the
capacity to cross-prime antigens is primarily the CD8a+ DCs
[26,27], there are studies that suggest other DC subsets may also
be capable of cross-presentation [28,29,30]. Furthermore, whether
Lm can directly infect specific DC subsets and if these DCs can
activate naı¨ve T cells remains unresolved. Given the reports of T
cell activation in the absence of CD11c+ cells in vivo [25], we
hypothesized that different antigen presenting cells (APCs) could
make varying contributions to induction of Lm-specific immunity.
Finally, the interplay between different APCs in priming of
adaptive immune responses has not been elucidated.
We demonstrate that CD8a+ DCs are the most susceptible to
infection ex vivo and the only subset capable of priming antigen
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specific T cells to Lm. CD11b+ DCs, while elaborating cytokines
in response to infection, did not elicit a strong CD8 T cell
response, and PDCs were relatively refractory to infection ex vivo.
Lm infected monocytes secreted high levels of TNFa and IL-12
p70, exhibiting key characteristics of inflammatory monocytes
[31]. Nevertheless, we find that the presence of these monocytes
can modulate the effector function and potency of CD8a+ DCs by
enhancing DC production of cytokines, but paradoxically
inhibiting T cell activation. Further analysis into the possible
mechanisms involved in this inhibition of T cell priming revealed
that TNFa and iNOS appear to be key players in this inhibition as
blockade of iNOS or TNFa each resulted in loss of this inhibition.
These findings underscore the complex coordination of both the
innate and adaptive players in immunity against Lm.
Results
CD8a+ DCs are most susceptible to direct Infection by Lm
The majority of studies on DC infection with Lm rely on in vitro-
generated, bone marrow-derived DCs (BMDCs) [32,33], but these
DCs may not reflect DCs in vivo. Hence, for this study, primary
APCs were isolated from B6 mice following FMS like Tyrosine
kinase 3 ligand (Flt3-L) mobilization with a B16 cell line
transduced to secrete Flt3-L (B16/Flt3-L) [34,35]. Flt3-L being a
growth factor for DCs, using the B16-Flt3L cell line allowed us to
expand DCs and monocytes to sufficient numbers in vivo. On D12–
16 post injection, DC subsets were isolated by flow cytometry-
based sorting. CD8a+ DCs were sorted as CD11chi CD11b2
PDCA-12, CD11b+ DCs were sorted as CD11chi CD11bhi
PDCA-12, and PDCs were sorted as CD11cint CD11b2PDCA-
1+. Spleen-derived monocytes were isolated as CD11b+ CD11c2.
CD11chi CD11b2 PDCA-12 DCs expressed high levels of CD8a
(Figure 1A). We found that the DCs isolated from Flt3-L mobilized
mice expressed levels of CD40, CD80, CD86 and MHC II
comparable to DCs in unmanipulated mice (Figure S1).
These sorted primary DC subsets were infected ex vivo with the
wild-type strain of Lm. Infections were performed with agitation in
order to minimize differences between subsets due to cell adherence.
Of the primary DC subsets the CD8a+ DCs were the most highly
infected and exhibited titers higher than seen in the monocyte
fraction (Figure 1B). CD11b+ DCs were infected at lower levels and
PDCs appeared remarkably refractory to infection. Surprisingly,
primary monocytes isolated were not as highly infected as the
CD8a+ DCs, although these monocytes may be more efficient at
killing intracellular bacteria, resulting in lower CFUs.
CD8a+ DCs present Lm-derived antigen
We next sought to compare the ability of the DC subsets to
present Lm-derived antigens and to test whether interactions with
DC and monocytes have any effect on T cell activation. For these
experiments, DC subsets were infected for 1 hr with Lm strains
engineered to express OVA SIINFEKL (Lm-WT-OVA). Cells were
washed and incubated overnight in gentamicin containing media in
the presence of B3Z T cells, a LacZ-inducible T cell hybridoma that
recognizes OVA257–264 SIINFEKL (SL8) [36]. CD8a
+ DCs were
most efficient at presenting antigen to the B3Z CTLs. No significant
T cell activation was detected from the infected CD11b+ DC or
PDC subset or from monocytes in this assay (Figure 1C). While both
CD8a+ DC and CD11b+ DC subsets demonstrated comparable
ability to present SL8 peptide, only the CD8a+ DCs were able to
present Lm-derived OVA antigen.
To assess the capacity of infected DCs to prime naı¨ve antigen-
specific T cells in vitro, isolated APCs were again infected with Lm-
WT-OVA and now co-cultured with purified naı¨ve OT1+ CD8+ T
cells, which recognize SL8 peptide in the context of H-2Kb [37].
IFNc secretion from these CD8+ T cells was assayed via
intracellular cytokine staining (ICS). In concurrence with the
antigen presentation result, CD8a+ DCs were most potent in
priming antigen-specific T cells (Figure 1D). There was no IFNc
detected from CD11b+ DCs or monocytes despite low levels of
infection.
We used an adoptive transfer system using CFSE labeled purified
OT1+ T cells, to study T cell priming in response to Lm infection in
vivo, Labeled T cells were adoptively transferred into wild-type B6
mice that were subsequently primed subcutaneously with
CD8a+DC, CD11b+ DC or monocytes infected with Lm ex vivo.
In order to limit spread of the bacteria from the ex vivo infected DCs
to other host DCs we used the Lm-ActA2 and Lm-ActA2-OVA
strains for infection in these experiments since this strain is deleted in
the ActA gene required for cell-to-cell invasion. While spread of
bacteria is still possible due to dissemination from the death of
infected APCs, we hoped to limit at least part of the mechanism of
bacterial spread. Consistent with our ex vivo data, only infected
CD8a+ DCs were able to elicit T cell proliferation in response to
Lm-ActA2-OVA (Figure 1E). There was no detectable CFSE
dilution in response to infected CD11b+ DCs or monocytes,
supporting the notion that these subsets are not capable of directly
priming T cells, nor can they effectively provide a source of antigen
that could be subsequently presented by endogenous host APCs.
Primary DCs infected ex vivo with Lm secrete low levels
of cytokine
Next we assessed the capacity of different APCs to produce
cytokine in response to Lm infection. DC subsets were again
isolated and infected ex vivo. 18 hrs post infection, culture
supernatants were harvested and assayed for TNFa, IL-12 p70,
and IFNa. Cytokine secretion from all DC subsets and monocytes
was very low (data not shown) compared to published results with
in vitro generated DCs such as BMDCs. Given the requirement of
IFNc for bacterial clearance and the fact that NK cell involvement
in the innate response could provide an initial burst of IFNc, we
cultured these primary DCs in the presence of IFNc. Upon
infection, low levels of TNFa were detected from CD11b+ DCs
and more significant levels of IL-12 p70 were detected from
CD8a+ DCs (Figure 2 A, B). There was also significant secretion of
IL-12 p70 and TNFa from monocytes. None of the APCs studied,
including PDCs, secrete detectable levels of IFNa and the addition
of IFNc had no effect on IFNa production (data not shown).
Interaction between DCs and monocytes during Lm
infection ex vivo enhances cytokine production
We next asked if co-culture of different DC subsets with
monocytes would modulate TNFa and IL-12 p70 secretion from
these DCs. DC subsets and monocytes were infected as described
before, washed and then incubated in gentamicin-containing
media with other uninfected DC subsets or monocytes. While a
significant increase in levels of TNFa was readily detectible from
co-cultures containing infected monocytes (Figure 3A), levels of
TNFa from infected DC co-cultures were much lower. No
enhancement of TNFa secretion was observed due to collabora-
tion between DC subsets. Co-cultures between infected DCs and
uninfected monocytes resulted in significant increases in cytokine
secretion even in the case of infected PDCs, and levels of TNFa
measured were comparable to those from infected monocytes. To
identify the source of cytokine production by ICS, we found that
both the infected DC and the monocytes, which were not directly
infected, produce TNFa (Figure 3B).
DC/Monocyte interaction in Listeria infection
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With regards to IL-12 p70, we saw enhanced secretion when
infected DCs were co-cultured with uninfected monocytes
(Figure 3C). While levels of IL-12 p70 from cultures including
infected CD8a+ DCs or monocytes alone were low, we observed a
5–10 fold enhancement in co-cultures between each of the infected
DC subsets and uninfected monocytes. Maximal levels of IL-12
p70 were observed in co-cultures between CD8a+ DCs and
uninfected monocytes, but modest increases were also measured
from infected CD11b+ DCs and PDCs, which could result from
maturation of these monocytes into TipDC-like cells.
Interaction between DCs and monocytes during Lm
infection ex vivo abrogates T cell priming
Given the marked enhancement in IL-12 p70 secretion in the
presence of monocytes, we studied the effect of this interaction
between CD8a+ DCs and monocytes on T cell activation. Having
Figure 1. CD8a+ DCs are most susceptible to Lm infection and elicit antigen specific T cell responses. (A) Splenocytes from Flt3-L
mobilized mice were stained with CD11b, PDCA-1 and CD11c; and sorted on a MoFlo sorter. CD8a+ DCs were sorted as CD11chi CD11b2 PDCA-12;
CD11b+ DCs as CD11chi CD11b+ PDCA-12; and PDCs as CD11cint CD11b2 PDCA-1+. Monocytes were sorted as CD11c2 CD11b+ PDCA-12. CD8a+ DCs
were stained with CD8a to confirm expression. (B) Sorted DC subsets were infected with Lm-WT or Lm-WT-OVA at an MOI of 1 for one hour and
incubated in media containing gentamicin for 1 hr at 37uC. Lm-WT infected cultures were then lysed and plated on BHI agar plates overnight at 37uC.
Lm colonies forming units (CFU) were enumerated. (C) Infected DCs were co-incubated overnight at 37uC with the LacZ inducible B3Z T cell
hybridoma. (D) Infected DCs were incubated at 37uC with purified naı¨ve OT-1 transgenic T cells for 4 days. On D4 T cells were washed and
restimulated with B6 splenocytes pulsed with SL8 peptide for 5 hours in the presence of brefeldin A. T cell activation was assessed intracellular
staining (ICS) for IFNc in response to the denoted uninfected APCs (shaded histograms) or APCs either loaded with SL8 peptide or infected with Lm
where indicated (solid line). Numbers represent geometric mean fluorescence intensities (MFI). (E) CD8+ OT1 T cells were isolated and labeled with
5 mM CFSE. 16106 cells were adoptively transferred intravenously (i.v.) into naı¨ve B6 mice. Sorted CD8a+ DCs, CD11b+ DCs or monocytes were
infected with either Lm-actA2, Lm-actA2-OVA or pulsed with 1 mM SL8 peptide and were injected subcutaneously (s.c.) into the foot-pad 8 hours
later. Popliteal lymph nodes were harvested at 60 hrs, and proliferation was determined via CFSE dilution assessed by flow cytometry. Numbers
represent percent divided cells. Data are representative of at least three independent experiments.
doi:10.1371/journal.pone.0019376.g001
DC/Monocyte interaction in Listeria infection
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determined that CD8a+ DCs were not just the most efficient but
the only DC subsets capable of inducing T cell priming and CTL
differentiation, we chose to focus on this subset for further studies.
CD8a+ DCs infected with Lm-WT-OVA were co-cultured with
monocytes, and OVA-reactive OT1+ T cells. IL-2, GM-CSF and
IFNc production were assayed by ICS on D4. Co-cultures
between CD8a+ DC and monocytes did not enhance T cell
activation (data not shown) or IFNc secretion. Surprisingly, direct
contact with infected monocytes abrogated IL-2, GM-CSF and
IFNc secretion from OT1 T cells (Figure 4A, B, C). Interestingly,
co-culture with uninfected monocytes did not result in abrogation,
suggesting that infection of monocytes was required for inhibition
(data not shown). In addition, this inhibition was also apparent in
trans-well cultures (Figure 4 D).
To test whether a similar effect is seen in vivo, we immunized
mice with CD8a+ DC and monocytes that were co-infected ex vivo
and assessed T cell responses via CFSE dilution. Co-immunization
with infected CD8a+ DC and monocytes resulted in abrogated T
cell proliferation in vivo (Figure 4E, left column). To assess the role
of cross-presentation in priming this immune response, we also
repeated these studies in beta2-microglobulin deficient (b2m2/2)
mice [38,39]. Responses to Lm in b2m2/2 mice mimicked the
results seen in wild-type mice, and infected CD8a+ DCs were able
to elicit a response (Figure 4E, right column). Since these mice are
unable to cross-present Lm-derived antigens on MHC I, we can
assume the T cell activation elicited is a direct response to ex vivo
infected DCs and not to other host-derived cells. Consistent with
our in vitro data, we also observed a decrease in T cell priming with
co-administration of CD8a+ DC and monocyte (Figure 4E). This
effect was particularly evident in b2m2/2 recipient mice. We also
analyzed the average number of cell divisions in these populations
using the division index based upon CSFE dye dilution (Figure 4F).
The division index represents the average number of cell divisions
of all cells in the population (i.e. it includes the undivided cells).
Once again, the data revealed that the average number of T cell
divisions in co-cultures in both B6 mice (top panel) and b2m2/2
mice (bottom panel) is decreased modestly compared to T cell
cultures with infected CD8a+ DCs only. These combined data
suggest that antigen specific T cells can be primed via direct
presentation and that cross-presentation may not necessarily be
the primary mechanism for T cell activation in response to Lm in
vivo. In addition, the magnitude of the response in b2m2/2 mice
was somewhat greater compared to that in the wild-type mice. We
speculate that the increase may be due to differences in the
cytokine milieu or stimulatory signals yet to be elucidated in the
b2m2/2 mice.
With these observed suppressive effects, we phenotypically
characterized the sorted splenic monocytes (CD11c2CD11b+
cells). The monocytes isolated from Flt3-L mobilized spleens for
our study were Ly6C+ Gr-1+ Ly6G2 (Figure 5A), a phenotype
consistent with TipDCs [6,40]. This finding suggests that the
sorted splenic monocytes may represent the cells that develop into
TipDCs with Lm infection [6]. To examine whether either TNFa
or nitric oxide (NO) mediates the observed inhibition, we
incubated infected CD8a+ DCs and monocytes with OT1+
CD8+ T cells in the presence of TNFa or iNOS inhibitors.
Consistent with our prior results, the addition of monocytes to
CD8a+ DCs/T cell cultures dampened T cell proliferation
(Figure 5B). The addition of 1400W, an iNOS inhibitor, or a
neutralizing monoclonal antibody to TNFa resulted in a partial
but significant release from inhibition indicating that both these
molecules are involved in mediating T cell inhibition (Figure 5C).
There was no additive effect of blocking both inhibitors together
(data not shown). While a direct effect of these mediators on
CD8a+ DC cannot be excluded at this point, we hypothesize that
it is likely that these compounds mediate a more significant impact
on the co-cultured monocytes. While these molecules have been
implicated in bacterial clearance by TipDCs, it is surprising to find
that both these molecules can inhibit T cell activation. While
TNFa can contribute to the pro-inflammatory environment, this
cytokine my also lead to the terminal activation of antigen
presenting cells, perhaps contributing to increased apoptosis of the
presenting DCs and decreased persistence of antigen. These data
also highlight the delicate counterbalance between the simulta-
neous induction of both stimulatory and inhibitory pathways as a
result of microbial infection.
Discussion
In this study, we assessed the contributions of different DC
subsets and monocytes in generating an immune response against
the intracellular bacterium Lm. The spleen is a known site of Lm
infection. By infecting isolated splenic APCs ex vivo in the absence
of other cell types, we could dissect the specific contributions of
each subset and demonstrate that monocytes can influence CD8a+
DC function and dampen the subsequent adaptive T cell
responses. We also find that PDCs are strikingly refractory to
infection in vitro. In view of studies that have shown the detrimental
effects of type I IFNs on bacterial clearance [15,16,17], this lack of
participation in this anti-bacterial response may reflect the checks
and balances inherent in the host immune system to maintain a
productive response while limiting infection-induced immune-
mediated pathology. Nevertheless, one study has described the
activation of PDCs in response to intragastric infection with Lm in
vivo [41], and these data suggest a role for PDCs at the site of
bacterial entry that may require accessory cells or environmental
cues for involvement in the response.
Figure 2. Cytokine production by APCs in the presence of IFNc.
Sorted DC subsets were infected with Lm-WT and incubated overnight
at 37uC in the presence of gentamicin and 100 U/ml IFNc. At 18 to
20 hours post infection supernatants were assayed for (A) TNFa and (B)
IL-12 p70 production by ELISA. Data are representative of at least three
independent experiments.
doi:10.1371/journal.pone.0019376.g002
DC/Monocyte interaction in Listeria infection
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The monocytes isolated for our ex vivo experiments exhibited low
levels of infection but secrete high levels of inflammatory cytokines
(TNFa and IL-12 p70) in our hands, signature cytokines secreted
by classically activated macrophages [31]. Functional IL-12 p70
from monocytes has been reported to be produced by human
monocytes [42]. In addition, maximal cytokine secretion from
infected DCs (especially IL-12 p70 from CD8a+ DCs) is observed
when these DCs are co-cultured with monocytes. These findings
are in keeping with recent evidence highlighting the interplay
between innate mediators such as TipDCs early in an Lm-specific
response [40]. The monocytes isolated in our study are also Gr-
1+Ly6C+Ly6G2 and appear to be functionally similar to TipDCs
as they are able to secrete TNFa while appearing uninfected [6].
Our study also emphasizes the role of Lm-exposed monocytes as
important modulators of the adaptive response to Lm. The
enhanced production of IL-12 seen would presumably enhance
priming of antigen specific CD8+ T cells. Nevertheless, the
capacity of CD8a+ DCs to prime T cells and elicit T cell effector
function efficiently is in fact attenuated ex vivo and in vivo in the
presence of infected monocytes. These data are consistent with
several in vivo studies that have shown that T cell responses are
abrogated during the early stages of the Lm response [43,44].
Moreover, antigen specific responses to Lm in the spleens of
CCR2 deficient mice that are unable to recruit TipDCs are
enhanced compared to those in wild-type infected spleens [6]. We
also demonstrate that this inhibition of T cell activation was at
least in part due to the effects of iNOS and TNFa, two mediators
essential for antimicrobial defenses in vivo. While monocytes would
be the presumed source of iNOS, DCs may also represent another
source [45,46].
Thus, Lm-exposed monocytes exhibit distinct characteristics of
both TipDC like precursors and inflammatory monocytes and
may represent a unique subset capable of both enhancing and
abrogating different components of Lm-specific responses. During
Lm infection, monocytes may sense Lm infected DCs under
inflammatory conditions via some soluble mediator including
Figure 3. TNFa and IL-12 p70 from infected DC subsets is further increased with co-culture with monocytes. Sorted APCs were infected
with Lm-WT and incubated overnight in gentamicin media at 37uC. Infected subsets were co-cultured with uninfected sorted APCs (bold labels) as
indicated. Supernatants from the co-cultures were assayed for (A) TNFa and (C) IL-12 p70 by a Luminex-based multiplex cytokine assay. Data are
representative of at least three independent experiments. (B) For determination of TNFa secretion via ICS, Lm-infected DCs or monocytes or co-
cultures were incubated in gentamicin media for 16 hrs. Cultures were treated with brefeldin A for the final 12 hours at 37uC, and TNFa secretion was
assessed via flow cytometry. Data were gated on either CD11chi CD11b2, CD11chi CD11b+, CD11cint PDCA-1+ or CD11c2 CD11b+ events, and the
percentage of cells positive for TNFa was determined using FlowJo software. (Shaded histograms represent uninfected cells while empty histograms
with solid line represent Lm-WT infected cells). Data for CD11b+ DCs cultured with monocytes are shown here and are representative of two
independent experiments.
doi:10.1371/journal.pone.0019376.g003
DC/Monocyte interaction in Listeria infection
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Figure 4. Priming of T cells by APC co-cultures is attenuated in vitro and in vivo. Sorted CD8a+ DCs and monocytes were infected with Lm-
WT or Lm-WT-OVA at an MOI of 1 either individually or together in co-cultures. 104 infected DCs or monocytes were then cultured at 37uC with 105
purified OT-1 transgenic T cells. On Day 4 T cells were washed and re-stimulated with B6 total splenocytes pulsed with SL8 peptide for 5 hours in the
presence of brefeldin A. Production of (A) IL-2, (B) GM-CSF and (C) IFNc was determined via ICS, and MFI of cytokine staining was analyzed using
FlowJo software. (D) Lm-WT or Lm-WT-OVA infected CD8a+ DCs or monocytes were then cultured at 37uC with purified OT-1 transgenic T cells in the
bottom of a trans-well chamber. In the case of APC co-cultures, infected CD8a+ DCs were cultured with the T cells in the bottom of a trans-well
chamber while infected monocytes were seeded in the top of the trans-well chamber. IFNc secretion was assessed via ICS and MFI of cytokine
staining was determined using FlowJo software. (E) CD8+ OT1 T cells were isolated and labeled with 5 mM CFSE. 16106 cells were adoptively
transferred intravenously (i.v.) into either wild-type B6 (left column) or b2m2/2 (right column) mice. Sorted CD8a+ DCs or monocytes infected with
either Lm-actA2, Lm-actA2-OVA or pulsed with 1 mM SL8 peptide were injected subcutaneously (s.c.) into the foot-pad 8 hours later. Popliteal lymph
nodes were harvested at 60 hrs. CFSE dilution and cell division were determined using FlowJo software. Numbers in histograms represent percent
divided cells. Data shown in panels (A–E) are for one mouse per condition and are representative of at least three independent experiments. (F) The
DC/Monocyte interaction in Listeria infection
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elaborated cytokines or chemokines such as monocyte chemoat-
tractant protein-1 (MCP-1). Such Lm-exposed monocytes then
differentiate into TipDCs to secrete TNFa and NO. While
important for elaborating inflammatory cytokines crucial for
bacterial clearance and the innate immune response, these TipDC
like inflammatory monocytes appear to unexpectedly abrogate
adaptive responses. This paradoxical augmentation of DC
cytokine secretion but impairment in T cell stimulation could be
explained in light of the competing goals of clearing vs.
establishing durable protective immunity. CD8a+ DCs being the
primary splenic DC subset capable of cross-presentation are
uniquely situated to mount a potent immune response against
infectious pathogens. However in the case of Lm, these APCs are
also highly susceptible to infection, making them a liability to the
host as a conduit for disseminating the infection. Dampening an
immune response may be desirable to restrict tissue damage as a
result of unregulated release of microbicidal mediators such as
TNFa and NO. Alternatively, impairment of T cell responses to
infected DCs may represent an as yet unappreciated mechanism
by which Lm subverts the host to avoid detection and preserve its
intracellular niche.
Materials and Methods
Mice
Mice were purchased from the NIH/National Cancer Institute
(NCI), Charles River (Wilmington, MA) or Jackson Labs (Bar
Harbor, ME). Mice used in this study were wild-type C57BL/6 (B6)
mice, OT1 TCR transgenic mice [37], and beta 2-microglobulin
deficient (b2m2/2) mice [38,39]. Mice were housed in a specific
pathogen free facility and experiments were performed in an
appropriate biosafety level 2 (BSL2) facility as per UCSF protocol.
Bacterial strains
Listeria monocytogenes strains used were the wild-type Lm-WT (DP-
L4056), and the Lm-ActA2 (DP-L4029 DactA) mutant strain, in
addition to the isogenic strains containing the pPL2-LLO-OVA
cassette Lm-WT pPL2-LLO-OVA (Lm-WT-OVA) and Lm-ActA2
pPL2-LLO-OVA (Lm-ActA2-OVA) (Aduro Biotech, Berkeley,
CA). The in vivo 50% lethal dose [LD50] in B6 mice of the wild-
type strain is 56104 colony forming units (cfu) and the Lm-ActA2
strain is 16108 cfu, and have been described previously [47].
Peptides and Antibodies
OVA257–264 (SIINFEKL; SL8) peptide was synthesized by
Synpep Corporation (Dublin, CA). Antibodies used for DC
isolation were: CD11b FITC (clone M1/70; BioLegend, San
Diego, CA), PDCA-1 PE (Clone JF05-1C2.4.1; Miltenyi Biotec
Inc., Auburn, CA), PDCA-1 APC (Clone eBio927; eBiosciences,
San Diego, CA) and CD11c Alexa 647 (clone N418; home grown).
Antibodies used in this study were: CD40 PE/Cy5 (clone 1C10),
MHCII PE, (Clone M5/114.15.2), Va2+ TCR FITC (clone
B20.1), CD11c PE (clone HL3), CD4 PE (clone GK1.5), CD11b
PE (clone M1/70), CD8a PerCP (clone 53-6.7), CD25 APC (clone
PC61), Ly6C PE (clone AL-21), Ly6G PE (clone 1A8) from BD
Pharmingen (San Jose, CA); CD80 PE (clone 16-10A1), CD86
Pacific Blue (clone GL1), CD44 Pacific Blue (clone IM7), IL-2
Pacific Blue (clone JES6-5H4), GMCSF PE (clone MP1-22E9),
Gr-1 PE (clone RB6 8C5), Streptavidin PE-Cy7 from BioLegend
(San Diego, CA); CD62L PE (clone MEL 14), CD69 PE-Cy7
(clone H1.2F3), IFNc APC (clone XMG1.2), TNFa PE (clone
MP6-XT22), from eBiosciences (San Diego, CA).
Dendritic cell isolation
B6 Mice were injected subcutaneously in the right flank with
56106 B16-BL6 melanoma tumor cells engineered to secrete FMS
like Tyrosine kinase 3 ligand (Flt3-L) [48]. Spleens were harvested
between d12-d16, injected with 2 mg/ml Collagenase D (Roche,
San Francisco, CA) and incubated at 37uC for 20 minutes. Spleens
were then disrupted with the flat end of a syringe plunger, washed
and treated with Tris ammonium chloride buffer (TAC) to lyse the
red blood cells. Splenocytes were then stained with CD11b FITC,
PDCA-1 PE and CD11c Alexa 647, and DC subsets were sorted
on a MoFlo sorter (DakoCytomation, Fort Collins, CO) as
CD11chi CD11b2 PDCA-12 (CD8a+ DC), CD11chi CD11b+
PDCA-12 (CD11b+ DC), CD11c int CD11b2 PDCA-1+ (PDC).
Monocytes were sorted as the CD11c2 CD11b+ PDCA-12 subset.
Bacterial infections
Overnight cultures or log phase cultures of Lm strains were
grown in brain-heart infusion (BHI) media (Difco-BD Biosciences,
Figure 5. Inhibition of T cell priming by Gr-1+Ly6C+ monocytes
is mediated partly by TNFa and iNOS. (A) Sorted monocytes were
stained with antibodies against Gr-1, Ly6C and Ly6G and assessed by
flow cytometry. Dot plots are gated on CD11c2CD11b+ cells and
numbers in corners represent percentages of cells staining positive for
the given marker. Data are representative of two independent
experiments. (B) CD8a+ DCs and monocytes were infected with Lm-
WT or Lm-WT-OVA either individually or as a co-culture as described,
and 56104 APCs were incubated in gentamicin containing media with
105 purified CD8+ OT1+ T cells at a ratio of 2:1 (T:DC, or T:mono; final
cell count 1.56105) or 2:1:1 (T:DC:mono; final cell count 26105) for
60–70 hrs. T cell proliferation was assessed with the addition of
3H-thymidine for the final 16 hrs of incubation. (C) To determine the
role of TNFa and iNOS, samples infected as described in panel B were
incubated either in the presence or absence of 10 mg/ml of a
neutralizing monoclonal antibody against TNFa or 1400W, an inhibitor
of iNOS. Data are representative of two independent experiments.
doi:10.1371/journal.pone.0019376.g005
division indices for mice from 3 separate experiments (circles) are shown along with the averages for each condition (dashes). Analysis was performed
using the Proliferation algorithm in the Flowjo software.
doi:10.1371/journal.pone.0019376.g004
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CA) and used for infection as previously described [49]. Briefly,
sorted cells were incubated with Lm at a multiplicity of infection
(MOI) of 1. Samples were infected while rolling for 1 hr at 37uC
and then washed twice in media containing 50 mg/ml gentamicin
(Sigma-Aldrich, St. Louis, MO) to prevent growth of extracellular
bacteria. The infected cells were then incubated in gentamicin
media for the indicated length of time and assayed as described
below.
Colony forming unit (CFU) determination
Sorted DC subsets were infected at an MOI of 1 and incubated
for 1 hr at 37uC. Following infection, the cells were washed and
incubated in media containing 50 mg/ml gentamicin (Sigma-
Aldrich, St. Louis, MO) for approximately 1 hr at 37uC to kill
extracellular bacteria. The infected cells were then lysed in 0.5%
NP40 (Sigma-Aldrich, St. Louis, MO) and plated on BHI agar
plates. The plates were incubated overnight at 37uC and Lm
colonies were enumerated after 24–48 hrs as a measure of
infection for each DC subset.
B3Z T cell hybridoma assay
The B3Z T cell hybridoma is an OVA 257–264 (SIINFEKL;
SL8)/H-2Kb specific CD8+ T cell hybridoma that is LacZ-
inducible [36]. DC subsets infected as described were washed
and co-incubated with B3Z cells at a ratio of 1:1 in gentamicin
containing media. Cultures were incubated for 20–24 hours at
37uC and developed with CPRG substrate (CalBiochem, San
Diego, CA) for 2–4 hr at 37uC as described [36].
Assessment of cytokine responses
Infected DC subsets were cultured in gentamicin containing
media for 18–20 hrs in the presence or absence of 100 U/mL
IFNc (R&D, Systems, Minneapolis, MN). Supernatants were
harvested and assayed for IFNa using the murine IFNa ELISA kit
(PBL Biomedical Laboratories, Piscataway, NJ); or TNFa, IL-12
p40 and IL-12 p70 using multiplex cytokine assay kits (Bio-Rad;
Hercules, CA) as per the manufacturer’s protocol. Multiplex
cytokine assays were analyzed on a Luminex100 (Luminex;
Austin, TX). TNFa and IL-12 p70 were also measured using
ELISA kits from R&D Systems (Minneapolis, MN) and e-
Bioscience (San Diego, CA) as per the manufacturer’s protocols.
Alternatively for determination of TNFa secretion via intracellular
cytokine staining (ICS), Lm-infected DCs or monocytes or co-
cultures were incubated in gentamicin media for 16 hrs. Cultures
were treated with brefeldin A for the final 12 hours at 37uC and
fixed and permeabilized with BD cytofix/cytoperm buffers (BD
Biosciences, San Jose, CA). Cells were stained with antibodies
specific for TNFa, acquired on a FACS LSRII (BD Biosciences,
San Jose, CA), and gated on either CD11chi CD11b2, CD11chi
CD11b+, CD11cint PDCA-1+ or CD11c2 CD11b+ cells. The
percentage of cells positive for TNFa and geometric mean
fluorescence of staining was determined using FlowJo software
v6.6 (Treestar, Ashland, OR).
Intracellular staining for T cell activation
CD8+ OT1 T cells were isolated by negative or positive
selection from splenocytes of OT1 T cell receptor transgenic mice
[37] using a CD8+T cell isolation kit (either Miltenyi Biotec Inc.,
Auburn, CA or StemCell Technologies, Vancouver, BC, Canada).
OT1 CD8+ T cells were routinely found to be 90–95% pure. 104
Lm infected DCs or monocytes were co-incubated with 105 OT1
T cells in gentamicin media at 37uC for 4 days. Cells in culture
were at a final ratio of 10:1 (T:DC, T:mono; final cell count
1.16105) or 10:1:1 (T:DC:mono; final cell count 1.26105). For
trans-well experiments, monocytes in the co-culture wells
(T+DC+Mono) were seeded in the upper chamber of the trans-
well while T cells and DCs were cultured in the lower chamber.
Where DCs alone or monocytes alone were cultured with OT1 T
cells the APCs were seeded in the lower chamber with the T cells.
On D4 cells were washed and stimulated with splenocytes from B6
mice pulsed with 50 mg/ml SL8 peptide in the presence of
brefeldin A for 5 hours at 37uC. The cells were stained for Va2
and CD8, and fixed and permeabilized with BD cytofix/cytoperm
buffers (BD Biosciences, San Jose, CA). Cells were stained with
antibodies specific for IL-2, GM-CSF and IFNc and acquired on a
FACS LSRII (BD Biosciences, San Jose, CA). Data were gated on
Va2+ CD8+ events, and the percentage of cells positive for IL-2,
GM-CSF or IFNc and geometric mean fluorescence of staining
was determined using FlowJo software v6.6 (Treestar, Ashland,
OR).
In vivo T cell activation
CD8+ OT1 T cells were isolated as described above and labeled
with 5 mM carboxyfluorescein diacetate succinimidyl ester (CFSE;
Molecular Probes, Eugene, OR). 16106 cells were injected
intravenously (i.v.) into either naı¨ve B6 or b2m2/2 mice. Sorted
DC subsets infected with either Lm-ActA2, Lm-ActA2-OVA or
pulsed with 1 mM SL8 peptide were injected subcutaneously in
the foot-pads of these mice 8 hours later. Popliteal lymph nodes
were harvested at 60 hrs, and T cell proliferation was determined
via CFSE dilution. The division index of proliferated cultures was
derived by the formula: Division Index= (Proliferation
Index)6(Percent Divided), where the proliferation index is
the average number of cell divisions of the responder cells.
Samples were acquired on a BD FACS LSRII (BD Biosciences,
San Jose, CA) and data were gated on Va2+ CD8+ events. The
percentages of activated cells and CFSE analyses were determined
using FlowJo software (Treestar, Ashland, OR).
In vitro T cell proliferation
CD8+ OT1 T cells were purified as described. CD8a+ DCs and
monocytes were infected with Lm-WT or Lm-WT-OVA either
individually or as a co-culture as described and 56104 APCs were
cultured with 105 purified OT1+ T cells for 60–70 hrs. Cells in
culture were at a ratio of 2:1 (T:DC or T:mono; final cell count
1.56105) or 2:1:1 (T:DC:mono; final cell count 26105). T cell
proliferation was assessed with the addition of 3H-thymidine
(PerkinElmer, Boston, MA) for the final 16 hrs of incubation. To
determine the role of TNFa and iNOS, samples were incubated
either in the presence or absence of 10 mg/ml of a monoclonal
antibody against TNFa (clone MP6-XT22, Biolegend, San Diego,
CA) or 1400W (Sigma-Aldrich, St. Louis, MO), an inhibitor of
iNOS. Cultures were then harvested using a Tomtec Harvester 96
(Hamden, CT) and counted on a Wallac 1450 Microbeta Trilux
liquid scintillation counter (EG&G Wallac, Turku, Finland) using
Wallac Software version 2.7.
Supporting Information
Figure S1 Phenotype of DCs from Flt3-L mobilized mice
and DCs from unmobilized mice is similar. Total
splenocytes isolated from Flt3-L mobilized mice and from wild-
type mice were stained with antibodies against CD80, CD86,
CD40 and MHC II. Cells were gated on DC subsets identified
using the gating strategy described in Figure 1 A. Expression
levels of these markers were determined using FlowJo software.
Shaded histograms represent isotype control staining while empty
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histograms with solid line represent activation marker specific
staining. Numbers over gates represent cell frequency.
(TIF)
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